Profile data is unavailable for this security.
About the company
PT Indonesia Farma Tbk is an Indonesia-based pharmaceutical and medical device manufacturing company. It is primarily engaged in the manufacturing and distribution of pharmaceutical products, traditional medicines, medical devices, health supplements, toll manufacturing, and laboratory testing services. The Company’s segments include Medicine, Medical devices and others, and Engineering pharmaceutical. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices, and household health products. It carries out business activities to produce, either alone or under cooperation, for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.
- Revenue in IDR (TTM)206.24bn
- Net income in IDR-295.10bn
- Incorporated1996
- Employees21.00
- LocationIndofarma Tbk PTJl. Indofarma No. 1, Cikarang BaratBEKASI 17530IndonesiaIDN
- Phone+62 2 188323971
- Fax+62 2 188323972
- Websitehttps://indofarma.id/en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Pharma Indonesia Tbk PT | 3.55tn | 244.62bn | 151.78bn | 173.00 | -- | -- | 0.5496 | 0.0428 | 67,951.15 | 67,951.15 | 985,755.10 | 353,052.60 | 1.83 | 5.46 | 5.54 | 19,498,450,000.00 | 12.61 | 12.45 | 20.63 | 18.05 | 10.58 | 11.52 | 6.89 | 6.80 | 1.46 | 96.91 | 0.0007 | -- | 5.40 | 9.48 | -0.5787 | 10.62 | 14.01 | -- |
| Phapros Tbk PT | 856.09bn | -209.56bn | 248.64bn | 1.26k | -- | 0.638 | -- | 0.2904 | -249.48 | -249.48 | 1,019.16 | 463.99 | 0.547 | 2.36 | 1.88 | 649,537,700.00 | -13.71 | -2.15 | -21.02 | -4.11 | 41.26 | 48.61 | -25.06 | -3.95 | 1.02 | -2.19 | 0.6425 | -- | -25.80 | -7.60 | -3,721.67 | -- | -13.99 | -- |
| Millennium Pharmacon Internationl Tbk PT | 3.99tn | 16.80bn | 250.98bn | 1.18k | 14.94 | 0.8356 | 6.24 | 0.0628 | 13.19 | 13.19 | 3,135.74 | 235.76 | 2.17 | 6.55 | 4.68 | 3,382,665,000.00 | 0.9118 | 1.26 | 4.42 | 5.88 | 8.49 | 8.44 | 0.4208 | 0.5389 | 0.7363 | 1.36 | 0.7385 | 11.73 | 16.45 | 7.51 | -48.84 | 16.53 | 5.53 | 14.87 |
| Brigit Biofarmaka Teknologi Tbk PT | 145.91bn | 28.94bn | 251.74bn | 224.00 | 7.67 | 2.05 | 6.87 | 1.73 | 48.24 | 48.24 | 243.19 | 180.51 | -- | -- | -- | 772,028,600.00 | -- | -- | -- | -- | 46.84 | -- | 23.13 | -- | 5.94 | 135.63 | 0.0652 | -- | 111.89 | -- | 145.75 | -- | -- | -- |
| Indofarma Tbk PT | 206.24bn | -295.10bn | 392.03bn | 21.00 | -- | -- | -- | 1.90 | -95.22 | -95.22 | 66.55 | -287.47 | 0.3078 | 4.86 | 3.42 | 261,731,600.00 | -44.04 | -22.37 | -- | -86.55 | -18.08 | 10.25 | -143.08 | -24.49 | 0.1006 | -67.63 | -- | -- | -59.82 | -31.14 | 53.61 | -- | -30.35 | -- |
| Ikapharmindo Putramas Tbk PT | 379.27bn | -27.76bn | 424.53bn | 994.00 | -- | 1.98 | -- | 1.12 | -16.48 | -16.48 | 225.13 | 127.12 | 0.8121 | 3.63 | 1.74 | 362,592,000.00 | -5.94 | -- | -10.96 | -- | 43.12 | -- | -7.32 | -- | 1.14 | -1.34 | 0.444 | -- | -6.59 | -- | -67.30 | -- | -- | -- |
| Merck Tbk PT | 1.10tn | 178.51bn | 1.41tn | 369.00 | 7.91 | 1.69 | 6.36 | 1.29 | 398.45 | 398.45 | 2,448.93 | 1,859.85 | 1.15 | 1.74 | 6.55 | 2,917,872,000.00 | 18.74 | 14.65 | 21.71 | 18.93 | 40.15 | 39.72 | 16.27 | 14.77 | 3.79 | -- | 0.0179 | 73.42 | 7.83 | 6.84 | -13.90 | 14.42 | -10.51 | 5.51 |
| Darya-Varia Laboratoria Tbk PT | 2.12tn | 173.09bn | 1.81tn | 1.31k | 10.45 | 1.18 | 7.43 | 0.852 | 154.54 | 154.54 | 1,895.66 | 1,370.50 | 0.9154 | 2.14 | 3.02 | 1,671,758,000.00 | 7.46 | 7.52 | 10.33 | 10.17 | 53.93 | 52.01 | 8.15 | 7.90 | 1.83 | -- | 0.0005 | 57.94 | 10.40 | 2.86 | 6.70 | -6.78 | 11.73 | 0.5546 |
